Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep;135(9):1169-75.
doi: 10.1007/s00432-009-0557-9. Epub 2009 Feb 12.

Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy

Affiliations

Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy

Ioannis Zachos et al. J Cancer Res Clin Oncol. 2009 Sep.

Abstract

Purpose: We conducted a prospective study to determine whether expression of telomerase reverse transcriptase (hTERT) is associated with recurrence-free-survival (RFS) or development of invasive disease in patients with high risk superficial bladder cancer (SBC) that received adjuvant BCG immunotherapy.

Methods: Thirty patients with high-grade T1 tumors were evaluated. Pre-BCG TURBT and post-BCG specimens were analyzed for hTERT nucleolar expression by immunohistochemistry.

Results: Post-BCG hTERT expression was statistically significantly lower than pre-BCG hTERT expression. Pre-BCG hTERT nucleolar staining in more than 75% of cells was associated with worse RFS (9 months vs. not yet reached, P = 0.05), while post-BCG hTERT nucleolar staining in more than 50% of the cells was associated with worse RFS (6 months vs. not yet reached, P = 0.001) and development of invasive disease. In multivariate analysis, post-BCG hTERT expression was independently associated with RFS and development of invasive disease.

Conclusions: Immunohistochemical evaluation of hTERT may help define a subset of high risk SBC patients that will eventually fail BCG and may therefore benefit from early salvage cystectomy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
hTERT positive (a) and negative (b) samples obtained from the same patient pre- and post-BCG, respectively
Fig. 2
Fig. 2
Association between pre-BCG hTERT positivity (based on a cut-off of 75%) and recurrence free survival: pre-BCG hTERT positive patients had a worse recurrence free survival compared to patients with tumors that hTERT negative (median recurrence free survival 9 months vs. not yet reached respectively, log rank P = 0.05)
Fig. 3
Fig. 3
Association between post-BCG hTERT positivity and recurrence free survival: post-BCG hTERT positive patients had a worse recurrence free survival compared to patients with tumors that hTERT negative (median recurrence free survival 6 months vs. not yet reached respectively, log rank P = 0.001)

References

    1. Blackburn EH (1991) Structure and function of telomeres. Nature 350:569–573. doi:10.1038/350569a0 - DOI - PubMed
    1. Brustmann H (2005) Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study. Gynecol Oncol 98:396–402. doi:10.1016/j.ygyno.2005.04.035 - DOI - PubMed
    1. Chen KY, Lee LN, Yu CJ et al (2006) Elevation of telomerase activity positively correlates to poor prognosis of patients with non-small cell lung cancer. Cancer Lett 240:148–156. doi:10.1016/j.canlet.2005.09.005 - DOI - PubMed
    1. Dalerba P, Guiducci C, Poliani PL et al (2005) Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells. Cancer Res 65:2321–2329. doi:10.1158/0008-5472.CAN-04-3678 - DOI - PubMed
    1. Domont J, Pawlik TM, Boige V et al (2005) Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis. J Clin Oncol 23:3086–3093. doi:10.1200/JCO.2005.06.944 - DOI - PubMed

MeSH terms